本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

66.25
-0.9500-1.41%
盘后66.250.00000.00%16:34 EDT
成交量:35.25万
成交额:2,359.45万
市值:28.12亿
市盈率:-41.67
高:68.87
开:67.01
低:66.09
收:67.20
52周最高:85.25
52周最低:38.51
股本:4,244.91万
流通股本:3,035.16万
量比:0.62
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-1.5900
每股收益(LYR):-1.5900
净资产收益率:-23.39%
总资产收益率:-9.45%
市净率:8.19
市盈率(LYR):-41.67

数据加载中...

2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/17

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]